^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Iwilfin (eflornithine)

    i
    Other names: DFMO
    Company:
    Norgine, US WorldMeds
    Drug class:
    Ornithine decarboxylase inhibitor
    Related drugs:
    12d
    Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma (clinicaltrials.gov)
    P2, N=406, Not yet recruiting, Milton S. Hershey Medical Center
    New P2 trial • Pan tumor
    |
    cisplatin • doxorubicin hydrochloride • cyclophosphamide • ifosfamide • etoposide IV • vincristine • topotecan • Iwilfin (eflornithine)
    8ms
    DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma (clinicaltrials.gov)
    P1/2, N=15, Recruiting, Montefiore Medical Center | Not yet recruiting --> Recruiting
    Enrollment open
    |
    Iwilfin (eflornithine)
    10ms
    DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma (clinicaltrials.gov)
    P1/2, N=15, Not yet recruiting, Montefiore Medical Center
    New P1/2 trial
    |
    Iwilfin (eflornithine)